Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors

被引:51
|
作者
Tian, You-yong
Tang, Cui-Ju
Wang, Jia-ning
Feng, Yuan
Chen, Xiao-wu
Wang, Lan
Qiao, Xian
Sun, Sheng-gang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Union Hosp, Dept Neurol, Wuhan 430022, Peoples R China
[2] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Neurol, Nanjing 210006, Peoples R China
[3] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Oncol, Nanjing 210006, Peoples R China
[4] Affiliated Peoples Hosp, Yunyang Med Coll, Inst Clin Med, Shiyan 442000, Peoples R China
关键词
adeno-associated virus; endothelial growth factor; neurodegeneration; Parkinson's disease; ENDOTHELIAL GROWTH-FACTOR; DOPAMINERGIC-NEURONS; MESENCEPHALIC CELLS; VIRUS VECTOR; IN-VITRO; NEUROPROTECTION; TRANSDUCTION; DEGENERATION; EXPRESSION; BRAIN;
D O I
10.1016/j.neulet.2007.05.033
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Vascular endothelial growth factor (VEGF) is a specific angiogenic peptide, which has been identified to play a critical role in neurodegeneration, and has beneficial effects on neurons. In this study, we investigated whether neurodegeneration in a rat model of Parkinson disease could be prevented by VEGF gene transfer mediated by adeno-associated virus (AAV) vectors. Our results demonstrated that a single injection of a VEGF-expressing AAV vector into striatum improved the rotational behavior of rat Parkinson disease models, and promoted the survival of dopaminergic neurons and fibers. Meanwhile. AAV-VEGF injection significantly increased the reactive astrocytes and the levels of glial cell line-derived neurotrophic factor in striatum, but did not induce extra angiogenesis and remarkable disorder of blood-brain barrier. We thus conclude that intrastriatal delivery of VEGF gene mediated by AAV has favorable effects on the dopaminergic neurons in a rat Parkinson disease model. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 50 条
  • [21] Treatment of human disease by adeno-associated viral gene transfer
    Kenneth H. Warrington
    Roland W. Herzog
    Human Genetics, 2006, 119 : 571 - 603
  • [22] Treatment of human disease by adeno-associated viral gene transfer
    Warrington, Kenneth H., Jr.
    Herzog, Roland W.
    HUMAN GENETICS, 2006, 119 (06) : 571 - 603
  • [23] Gene therapy for Parkinson's disease using adeno-associated- and adeno-viral vectors
    Paterna, JC
    Mura, A
    Kuhl, C
    Büeler, H
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 201 - 201
  • [24] Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases
    Auricchio, A
    Rolling, F
    CURRENT GENE THERAPY, 2005, 5 (03) : 339 - 348
  • [25] Adeno-associated viral vectors deliver gene vaccines
    Wei, Lai
    Yu, Peng
    Wang, Haomeng
    Liu, Jiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 281
  • [26] Adeno-associated gene transfer viral vectors for remyelination therapies in genetic leukodystrophies
    Bongarzone, E.
    Gray, S.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 13 - 13
  • [27] Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention
    Brady, Jacqueline M.
    Baltimore, David
    Balazs, Alejandro B.
    IMMUNOLOGICAL REVIEWS, 2017, 275 (01) : 324 - 333
  • [28] Strategies for gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors
    Ozawa, K
    Fan, D
    Ogawa, M
    Urabe, M
    Kume, A
    Monahan, J
    Nakano, I
    BIOGENIC AMINES, 1999, 15 (01) : 21 - 37
  • [29] Designer gene delivery vectors: Molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer
    Kwon, Inchan
    Schaffer, David V.
    PHARMACEUTICAL RESEARCH, 2008, 25 (03) : 489 - 499
  • [30] Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene Transfer
    Inchan Kwon
    David V. Schaffer
    Pharmaceutical Research, 2008, 25